Activity of a Novel Anti-Inflammatory Agent F-3,6′-dithiopomalidomide as a Treatment for Traumatic Brain Injury

Traumatic brain injury (TBI) is a major risk factor for several neurodegenerative disorders, including Parkinson’s disease (PD) and Alzheimer’s disease (AD). Neuroinflammation is a cause of later secondary cell death following TBI, has the potential to aggravate the initial impact, and provides a th...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsueh, Shih Chang, Scerba, Michael T., Tweedie, David, Lecca, Daniela, Kim, Dong Seok, Baig, Abdul Mannan, Kim, Yu Kyung, Hwang, Inho, Kim, Sun, Selman, Warren R., Hoffer, Barry J., Greig, Nigel H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9598880/
https://www.ncbi.nlm.nih.gov/pubmed/36289711
http://dx.doi.org/10.3390/biomedicines10102449

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9598880/
https://www.ncbi.nlm.nih.gov/pubmed/36289711
http://dx.doi.org/10.3390/biomedicines10102449

Ejemplares similares